Hims Wants to Keep Mailing You Copycat GLP-1s. It’s Getting Trickier. | Big Take скачать в хорошем качестве

Hims Wants to Keep Mailing You Copycat GLP-1s. It’s Getting Trickier. | Big Take

When a shortage of brand-name weight-loss drugs like Ozempic and Wegovy cleared the way for companies like Hims to fill the gap with cheaper, compounded versions, customers came flocking. But in February, the US Food and Drug Administration announced the shortage was over, leaving the company's strategy in flux and some investors worried. On today’s Big Take podcast, host David Gura and Bloomberg healthcare reporter Madison Muller track how Hims became the king of copycat weight-loss drugs and what’s next for the company as it fights to hold onto the crown. Read more: How Hims Became the King of Knockoff Weight-Loss Drugs (https://www.bloomberg.com/news/featur...) Cheap Ozempic Knockoffs Are Suddenly Everywhere. Are They Safe? (https://www.bloomberg.com/news/articl...) The Weight-Loss Drug Boom’s Prescription Problem (https://www.bloomberg.com/news/articl...) Listen and follow The Big Take on Apple Podcasts (https://podcasts.apple.com/us/podcast..., Spotify (https://open.spotify.com/show/3xau7gw...) or wherever you get your podcasts. See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information. The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon. Subscribe to Bloomberg Podcasts: https://bit.ly/BloombergPodcasts Listen to more of The Big Take:    • The Big Take | Bloomberg Podcasts   #Bloomberg #Podcast #News #Business #Economy #TheBigTake Visit us: https://www.bloomberg.com/podcasts Follow Bloomberg Podcasts on Twitter:   / podcasts   Visit our other YouTube channels: Bloomberg Television:    / @markets   Bloomberg Originals:    / bloomberg   Quicktake:    / @bloombergquicktake   For coverage on news, markets and more: http://www.bloomberg.com/video Hims Wants to Keep Mailing You Copycat GLP-1s. It’s Getting Trickier.